Cheap labor and global supply chains are among the obstacles to President Trump's plan to bring generic drug manufacturing back home. This GujjuTicks brief summarizes the headline for local readers; read the full story on the publisher site.
This is a short GujjuTicks summary for discovery. Full reporting and quotes belong to the original publisher.